II. Pathophysiology

  1. See Clonidine
  2. Clonidine acts at 2 sites
    1. Central Acting Adrenergic Agonists (alpha-2 receptors)
      1. Inhibits CNS preganglionic sympathetic signals, lowering Blood Pressure
      2. Results in increased parasympathetic effects and side effects (e.g. sedation)
    2. Imidazoline receptors
      1. Imidazoline-1 has hypotensive effects
      2. Imidazoline-2 may have Antidepressant effects (acting at MAO-A and MAO-B receptors)
      3. Imidazoline-3 appears to affect Glucose homeostasis
  3. Imidazoline Poisonings result in Clonidine-Like Toxicity (especially in children, and may be managed in similar ways)
    1. Clonidine Overdose (including Clonidine patch)
    2. Dexmedotomidine (e.g. veterinary Anxiolytic medications)
    3. Child ingestion of topicals
      1. General
        1. Very large ingestions may result when bottles are inverted
        2. Rapid absorption from Gastrointestinal Tract with effect onset in first 20-30 minutes
        3. Gastric Decontamination is typically ineffective (rapid onset) and unsafe (altered LOC)
    4. Rapid absorption
      1. Oxymetazoline (Afrin)
      2. Naphazoline (Clear Eyes)
      3. Tetrahydrozoline (Visine)
      4. Xylometazoline (Oltrivin)

III. Findings: Signs and Symptoms

  1. Alpha-2 Agonism
    1. Bradycardia
    2. Hypotension
      1. Brief Hypertension may result from peripheral alpha effect, but this typically resolves by presentation
    3. Hypothermia
  2. Opioid-Mimic Effects
    1. Apnea
    2. Mental status change (to Coma)
    3. Pinpoint Pupils (Miosis)
    4. Respiratory Depression

IV. Differential Diagnosis

V. Management: Adults

  1. ABC Management
  2. Naloxone
    1. Indicated in respiratory depression and apnea or significant CNS depression
    2. Initial
      1. No respiratory depression: 0.1 to 0.4 mg IV or IM
      2. Respiratory depression: 1 to 2 mg IV or IM
    3. Next, if no response or incomplete response
      1. Give 2 mg IV or IM every 3-5 minutes to a total of 10 mg total maximum
      2. Redosing may be needed due to short naloxone Half-Life
  3. Atropine
    1. Indicated in severe Sinus Bradycardia
    2. Atropine 0.5 to 1 mg IV (may repeat after 3 to 5 min, up to a maximum total dose of 3 mg)
  4. Vasopressors
    1. Indicated for Hypotension refractory to Intravenous Fluids
    2. Norepinephrine or Epinephrine IV

VI. Management: Children

  1. ABC Management
  2. Naloxone
    1. Initial
      1. No respiratory depression: 0.1 mg/kg to 0.4 mg IV or IM
      2. Respiratory depression: 1 to 2 mg IV or IM
    2. Next, if no response or incomplete response
      1. Give 2 mg IV or IM every 3-5 minutes to a total of 10-20 mg
  3. Atropine
    1. Indicated in Severe Bradycardia
    2. Start: Atropine 0.02 mg/kg up to 0.16 mg IV
    3. Maximum: Atropine 0.5 mg/kg IV
  4. Vasopressors
    1. Indicated for Hypotension refractory to Intravenous Fluids
    2. Norepinephrine or Epinephrine IV

VII. Management: Disposition

  1. Admit all symptomatic patients
  2. May discharge if asymptomatic at 6 hours after ingestion

VIII. References

Images: Related links to external sites (from Bing)

Related Studies

Ontology: Clonidine overdose (C0573261)

Concepts Injury or Poisoning (T037)
SnomedCT 296389000
English clonidine overdose, Clonidine overdose, Clonidine overdose (disorder)
Spanish sobredosis de clonidina (trastorno), sobredosis de clonidina